Literature DB >> 1845601

Microsomal ethanol oxidizing system: transcriptional and posttranscriptional regulation of cytochrome P450, CYP2E1.

F J Gonzalez1, T Ueno, M Umeno, B J Song, R L Veech, H V Gelboin.   

Abstract

CYP2E1 is solely responsible for microsomal P450-mediated ethanol oxidation activity. This enzyme is also involved in a pathway leading to gluconeogenesis from ketone bodies and in metabolic activation of numerous foreign compounds to intermediates that can be toxic to cells. Metabolic activation of certain procarcinogens by CYP2E1 may also lead to cell transformation. Regulation of CYP2E1 is especially intriguing. The CYP2E1 gene is transcriptionally activated in rat liver from a dormant state within a few hours after birth. This activation is due in part to the participation of a transcription factor designated hepatocyte nuclear factor 1 or HNF-1. In adult animals, constitutive expression of the enzyme is controlled to some degree by growth hormone. CYP2E1 is also regulated by many of its substrates through a substrate-induced stabilization of the enzyme. Under extreme conditions of fasting and uncontrolled diabetes CYP2E1 mRNA is stabilized.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1845601

Source DB:  PubMed          Journal:  Alcohol Alcohol Suppl        ISSN: 1358-6173


  9 in total

Review 1.  Role of variability in explaining ethanol pharmacokinetics: research and forensic applications.

Authors:  Ake Norberg; A Wayne Jones; Robert G Hahn; Johan L Gabrielsson
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

Review 2.  A Unifying Hypothesis Linking Hepatic Adaptations for Ethanol Metabolism to the Proinflammatory and Profibrotic Events of Alcoholic Liver Disease.

Authors:  Zhi Zhong; John J Lemasters
Journal:  Alcohol Clin Exp Res       Date:  2018-09-17       Impact factor: 3.455

3.  Nicotinamide N-oxidation by CYP2E1 in human liver microsomes.

Authors:  Alexander Michael Real; Shangyu Hong; Pavlos Pissios
Journal:  Drug Metab Dispos       Date:  2012-12-21       Impact factor: 3.922

Review 4.  Induction of drug metabolising enzymes: pharmacokinetic and toxicological consequences in humans.

Authors:  U Fuhr
Journal:  Clin Pharmacokinet       Date:  2000-06       Impact factor: 6.447

5.  Histone modification-mediated CYP2E1 gene expression and apoptosis of HepG2 cells.

Authors:  Hui Yang; Yuqiang Nie; Yuyuan Li; Yu-Jui Yvonne Wan
Journal:  Exp Biol Med (Maywood)       Date:  2010-01

6.  Molecular cloning and expression of novel alternatively spliced cytochrome P450 2E1 mRNAs in humans.

Authors:  Mario Bauer; Olf Herbarth; Gabi Aust; Carolin Graebsch
Journal:  Mol Cell Biochem       Date:  2005-12       Impact factor: 3.396

7.  Polymorphisms of ethanol-oxidizing enzymes in alcoholics with inactive ALDH2.

Authors:  S Higuchi; T Muramatsu; S Matsushita; M Murayama; M Hayashida
Journal:  Hum Genet       Date:  1996-04       Impact factor: 4.132

8.  An approach for mixture testing and prioritization based on common kinetic groups.

Authors:  Albert Braeuning; Denise Bloch; Mawien Karaca; Carsten Kneuer; Stefanie Rotter; Tewes Tralau; Philip Marx-Stoelting
Journal:  Arch Toxicol       Date:  2022-03-19       Impact factor: 6.168

Review 9.  Hepatic, Extrahepatic and Extracellular Vesicle Cytochrome P450 2E1 in Alcohol and Acetaminophen-Mediated Adverse Interactions and Potential Treatment Options.

Authors:  Santosh Kumar; Bhupesh Singla; Ajay K Singh; Stacey M Thomas-Gooch; Kaining Zhi; Udai P Singh
Journal:  Cells       Date:  2022-08-23       Impact factor: 7.666

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.